These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 39569)

  • 1. Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
    Halbhübner K; Herken H; Loos D
    Arzneimittelforschung; 1978; 28(10):1743-52. PubMed ID: 39569
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of dopamine agonists on parkinson-like muscle rigidity induced by 6-aminonicotinamide.
    Loos D; Halbhübner K; Kehr W; Herken H
    Neuroscience; 1979; 4(5):667-76. PubMed ID: 156312
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic agonists in animal models of parkinsonism.
    Poirier LJ
    Adv Neurol; 1975; 9():327-35. PubMed ID: 807089
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome.
    Goldstein M; Lieberman A; Battista AF; Lew JY; Matsumoto Y
    Acta Endocrinol Suppl (Copenh); 1978; 216():57-66. PubMed ID: 206089
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
    Ungerstedt U; Ljungberg T; Steg G
    Adv Neurol; 1974; 5():421-6. PubMed ID: 4531217
    [No Abstract]   [Full Text] [Related]  

  • 8. Repression of glial RNA transcription during the development of 6-aminonic-otinamide (6-AN)-induced acute gliopathy.
    Sarkander HI; Knoll-Köhler E; Cervos-Navarro J
    J Pharmacol Exp Ther; 1978 May; 205(2):503-14. PubMed ID: 147938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between animal models and clinical parkinsonism.
    Marsden CD; Duvoisin RC; Jenner P; Parkes JD; Pycock C; Tarsy D
    Adv Neurol; 1975; 9():165-75. PubMed ID: 1146651
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
    de Yebenes JG; Fahn S; Lovelle S; Jackson-Lewis V; Jorge P; Mena MA; Reiriz J; Bustos JC; Magariños C; Martinez A
    Mov Disord; 1987; 2(3):143-58. PubMed ID: 2904648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of paraplegia produced by intrathecal 6-aminonicotinamide on motor units in the rat.
    Mano Y; Mano K; Mayer RF; Deshpande SS; Albuquerque EX
    Exp Neurol; 1979 Aug; 65(2):435-56. PubMed ID: 157879
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effects.
    Micieli G; Martignoni E; Cavallini A; Pacchetti C; Rossi F; Horowski R; Nappi G
    Funct Neurol; 1996; 11(6):317-25. PubMed ID: 9074912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.
    Herken H; Meyer-Estorf G; Halbhübner K; Loos D
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jun; 293(3):245-55. PubMed ID: 134291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modelling of the parkinsonian syndrome by the administration of kainic acid into the caudate nucleus].
    Kryzhanovskiĭ GN; Makul'kin RF; Shandra AA; Godlevskiĭ LS; Rozhkov VS
    Biull Eksp Biol Med; 1987 Jun; 103(6):650-3. PubMed ID: 3593943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopaminergic agonists in Parkinson disease].
    Dubois B; Agid Y
    Rev Prat; 1986 Jan; 36(5):207-14. PubMed ID: 3961400
    [No Abstract]   [Full Text] [Related]  

  • 18. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of levodopa responses by deprenyl (selegiline): an electrophysiological and behavioral study in the rat relevant to Parkinson's disease.
    Mercuri NB; Scarponi M; Federici M; Bonci A; Siniscalchi A; Bernardi G
    Ann Neurol; 1998 May; 43(5):613-7. PubMed ID: 9585355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.